2020 ASCO Virtual Direct™ Highlights

 

Avatar

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is There an OS Benefit With Maintenance PARPi?

By Total Health 1229 Videos FEATURING Carolyn Muller
348 views
October 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
GYN
19:19

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytored…

Total Health

C. Muller

24 views
07:40

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is …

Total Health

C. Muller

348 views
09:08

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Ol…

Total Health

C. Muller

128 views